PEN Penumbra, Inc. Common Stock
$327,56
Cena · Sie 18, 2026
Dane fundamentalne na dzień Lip 30, 2026
Zakres 52 tyg.
$221–$362
75% of range
Ocena Analityków
HOLD
20 analysts
Cena Docelowa
$362
+10% upside
P/E (TTM)
72.5
ROE
13.1%
Marża Zysku Netto
12.7%
O Penumbra, Inc. Common Stock Przegląd firmy z Wikipedii
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
Czytaj więcej
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end.
History
Penumbra was founded in 2004 and manufactures several medical devices but specializes in the neuro/vascular market and creates devices that help treat aneurysms and ischemic stroke.
In 2014, Penumbra launched its Apollo system, a device that “enables minimally invasive removal of deeply seated tissue and fluids in the brain,” allowing for otherwise inoperable blood clots to be removed.
In 2015 the company issued an initial public offering on the New York Stock Exchange. In 2018 the company acquired 40% of the outstanding shares of virtual reality joint venture MVI Health. In 2017 the company acquired the Italian distributor Crossmed.
Criticism
Criticism of Penumbra has followed various aspects of its products and business practices. In 2016 a lawsuit claimed the Penumbra Coil 400 caused brain damage after surgery. The company's specialized catheter has been linked to the deaths of stroke patients, and it was a target of stock short sellers in 2020. According to the Foundation for Financial Journalism, this is a significant dilemma.
A request has been sent to The SEC and U.S. Food and Drug Administration to launch an investigation. A scientist who has published research articles showing the reliability of Penumbra's medical products is (allegedly) an internet fabrication.
Recalls
In 2011 the company recalled its Penumbra Coil 400. In 2017 the company recalled a 3D revascularization device. In 2020 the company recalled one of its catheter used during heart surgery due to increased risk of mortality and serious injury.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
PEN Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$327.56
Kapitalizacja Rynkowa
$12.85B
P/E (TTM)
72.5
EPS (TTM)
$4.52
Przychody (TTM)
$1.40B
Stopa dywidendy
—
ROE
13.1%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$221 – $362
PEN Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$1.40B
2018-12-31
→
2025-12-31
EPS
$4.52
2018-12-31
→
2025-12-31
Wolny przepływ pieniężny
$175M
2018-12-31
→
2025-12-31
Marże
12.7%
2018-12-31
→
2025-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
PEN
Mediana porównawcza
P/E (TTM)
72.5
27.5
P/S (TTM)
9.2
3.7
P/B
9.0
3.4
Price / FCF (Cena / FCF)
73.5
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
PEN
Mediana porównawcza
Gross Margin (Marża brutto)
67.1%
64.7%
Operating Margin (Marża Operacyjna)
13.5%
—
Net Profit Margin (Marża Zysku Netto)
12.7%
9.8%
ROA
10.6%
5.1%
ROE
13.1%
8.6%
ROIC
11.5%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
PEN
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
6.6
2.7
Quick Ratio (Wskaźnik Szybkości)
2.1
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
PEN
Mediana porównawcza
Revenue YoY (Przychody R/R)
17.5%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
18.3%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
20.2%
—
EPS YoY
1155.6%
—
Net Income YoY (Zysk Netto R/R)
1168.1%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
PEN
Mediana porównawcza
PEN Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
TRZYMAJ
20 analityków
- Mocne kupno 1 5,0%
- Kup 5 25,0%
- Trzymaj 14 70,0%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
12 analityków · 2026-08-14
Mediana
$374.00
Średnia
$361.83
Teraz
$327.56
Niski
$323.00
Wysoki
$374.00
Średni cel
$374.00
+14,2%
Średnia cel
$361.83
+10,5%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.05%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $0.88 | $1.20 | -0.32% |
| 31 marca 2026 | $0.82 | $1.09 | -0.27% |
| 31 grudnia 2025 | $1.18 | $1.12 | 0.06% |
| 30 września 2025 | $0.97 | $0.93 | 0.04% |
| 30 czerwca 2025 | $0.86 | $0.83 | 0.03% |
| 31 marca 2025 | $0.83 | $0.67 | 0.16% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| GMED | — | 22.3 | 16.7% | 18.3% | 12.1% | — |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
| TFX | — | -6.0 | 17.2% | -45.5% | -24.6% | 56.2% |
| NVST | $3.56B | 77.5 | 8.3% | 1.7% | 1.5% | 54.7% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 18
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.40B | $1.19B | $1.06B | $847M | $748M | $560M | $547M | · | $334M | $263M | |
| Cost of Revenue | $461M | $440M | $376M | $312M | $272M | $222M | $175M | · | $117M | $92M | |
| Gross Profit | $942M | $755M | $683M | $535M | $475M | $338M | $372M | · | $217M | $171M | |
| R&D Expense | · | · | · | · | · | · | · | · | $32M | $24M | |
| SG&A Expense | $663M | $574M | $506M | $450M | $378M | $287M | $273M | · | $184M | $148M | |
| Operating Expenses | $753M | $746M | $609M | $529M | $483M | $377M | $324M | · | $216M | $172M | |
| Operating Income | $189M | $9M | $74M | $6M | $-8M | $-39M | $48M | · | $1M | $-1M | |
| Interest Expense | · | · | $2M | $2M | $2M | · | · | · | · | · | |
| Interest Income | $16M | $14M | $7M | $2M | $3M | · | · | · | · | · | |
| Other Non-op | $893.0K | $-682.0K | $1M | $-2M | $-4M | $-343.0K | $-227.0K | · | $-1M | $-2M | |
| Pretax Income | $205M | $21M | $80M | $4M | $-11M | $-38M | $50M | · | $2M | $-869.0K | |
| Income Tax | $27M | $7M | $-11M | $6M | $-13M | $-19M | $3M | · | $-4M | $-16M | |
| Net Income | $178M | $14M | $91M | $-2M | $5M | $-16M | $48M | · | $5M | $15M | |
| EPS (Basic) | $4.57 | $0.36 | $2.37 | $-0.05 | $0.14 | $-0.44 | $1.39 | · | $0.14 | $0.49 | |
| EPS (Diluted) | $4.52 | $0.36 | $2.32 | $-0.05 | $0.14 | $-0.44 | $1.34 | · | $0.13 | $0.44 | |
| Shares (Basic) | 38,918,493 | 38,633,744 | 38,401,171 | 37,841,874 | 36,764,290 | 35,766,892 | 34,750,706 | · | 32,978,065 | 30,464,583 | |
| Shares (Diluted) | 39,291,828 | 39,268,037 | 39,216,564 | 37,841,874 | 37,881,180 | 35,766,892 | 36,265,999 | · | 35,319,103 | 33,478,078 | |
| EBITDA | $207M | $33M | $101M | $30M | $9M | $-26M | $56M | · | $5M | $950.0K |
Bilans 28
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $187M | $324M | $167M | $70M | $59M | $70M | $73M | · | $51M | $13M | |
| Short-term Investments | · | · | · | · | · | $195M | $117M | · | $164M | $116M | |
| Receivables | $190M | $168M | $202M | $203M | $134M | $115M | $106M | · | $58M | $43M | |
| Inventory | $432M | $407M | $388M | $334M | $264M | $220M | $153M | · | $95M | $73M | |
| Prepaid Expense | $50M | $37M | $36M | $30M | $29M | $19M | $15M | $12M | $15M | $19M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $7M | $9M | |
| Current Assets | $1.22B | $951M | $915M | $756M | $681M | $618M | $463M | $410M | $382M | $264M | |
| PP&E (Net) | $117M | $63M | $73M | $65M | $59M | $48M | $52M | · | $31M | $21M | |
| PP&E (Gross) | $194M | $137M | $132M | $113M | $97M | $78M | $73M | · | $41M | $28M | |
| Accum. Depreciation | $77M | $74M | $60M | $48M | $38M | $30M | $21M | · | $11M | $7M | |
| Goodwill | $167M | $166M | $166M | $166M | $166M | $8M | $8M | · | $8M | $0 | |
| Intangibles | $6M | $7M | $71M | $81M | $91M | $11M | $25M | · | $24M | $0 | |
| Other Non-current Assets | $41M | $41M | $26M | $13M | $13M | $9M | $3M | · | $1M | $487.0K | |
| Total Assets | $1.83B | $1.53B | $1.56B | $1.37B | $1.24B | $823M | $666M | $558M | $477M | $308M | |
| Accounts Payable | $35M | $31M | $27M | $27M | $13M | $14M | $15M | · | $7M | $4M | |
| Accrued Liabilities | $132M | $112M | $111M | $106M | $100M | $86M | $68M | $58M | $45M | $32M | |
| Current Liabilities | $183M | $158M | $151M | $145M | $123M | $106M | $91M | $70M | $52M | $36M | |
| Capital Leases | $183M | $187M | $197M | $199M | $137M | $44M | $47M | $47M | · | · | |
| Deferred Tax | · | · | · | · | · | · | $4M | · | $3M | $824.0K | |
| Other Non-current Liabilities | $12M | $15M | $5M | $3M | $4M | $8M | $15M | · | $18M | $824.0K | |
| Total Liabilities | $399M | $382M | $377M | $372M | $290M | $185M | $180M | $135M | $76M | $42M | |
| Common Stock | $39.0K | $38.0K | $39.0K | $38.0K | $37.0K | $36.0K | $35.0K | · | $33.0K | $31.0K | |
| Paid-in Capital | $1.19B | $1.10B | $1.05B | $963M | $911M | $598M | $431M | · | $397M | $274M | |
| Retained Earnings | $238M | $60M | $135M | $44M | $46M | $41M | $58M | · | $2M | $-3M | |
| AOCI | $4M | $-6M | $-3M | $-8M | $-3M | $3M | $-2M | · | $2M | $-5M | |
| Stockholders' Equity | $1.43B | $1.15B | $1.18B | $999M | $954M | $638M | $486M | · | $400M | $267M | |
| Liabilities + Equity | $1.83B | $1.53B | $1.56B | $1.37B | $1.24B | $823M | $666M | $558M | $477M | $308M | |
| Shares Outstanding | 39,229,670 | 38,490,836 | 38,681,549 | 38,107,977 | 37,578,483 | 36,414,732 | 35,001,581 | · | 33,685,146 | 31,108,828 |
Przepływy pieniężne 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $17M | $24M | $27M | $24M | $16M | $13M | $8M | · | $4M | $2M | |
| Stock-based Comp | $59M | $46M | $51M | $37M | $66M | $26M | $21M | · | $18M | $15M | |
| Deferred Tax | $21M | $-16M | $-25M | $1M | $-15M | $-20M | $1M | · | $-5M | $-13M | |
| Amort. of Intangibles | $712.0K | $5M | $10M | $9M | $3M | $1M | $1M | · | $418.0K | $0 | |
| Restructuring | · | $5M | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-37M | $101M | $-46M | $-116M | $-63M | $-36M | $-53M | · | $-9M | $-32M | |
| Operating Cash Flow | $239M | $168M | $97M | $-56M | $10M | $-33M | $27M | · | $13M | $-13M | |
| CapEx | $64M | $21M | $15M | $19M | $21M | $25M | $22M | · | $13M | $14M | |
| Investing Cash Flow | $-405M | $78M | $-16M | $55M | $-22M | $-104M | $-13M | · | $-78M | $687.0K | |
| Stock Issued | · | · | · | $0 | $0 | $135M | $0 | · | $106M | $0 | |
| Stock Repurchased | $0 | $100M | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $0 | $-100M | · | $0 | $0 | $135M | $0 | · | $106M | · | |
| Financing Cash Flow | $27M | $-87M | $16M | $12M | $836.0K | $135M | $-9M | · | $104M | $7M | |
| Net Change in Cash | $-138M | $157M | $98M | $10M | $-10M | $-3M | $5M | · | $37M | $-6M | |
| Taxes Paid | $15M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $175M | $147M | $82M | $-75M | $-12M | $-58M | $5M | · | $159.0K | $-26M | |
| Levered FCF | · | · | $80M | · | · | · | · | · | · | · |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.1% | 63.2% | 64.5% | 63.2% | 63.6% | 60.3% | 68.0% | · | 65.1% | 64.9% | |
| Operating Margin | 13.5% | 0.78% | 7.0% | 0.72% | -1.0% | -7.0% | 8.7% | · | 0.35% | -0.51% | |
| Net Margin | 12.7% | 1.2% | 8.6% | -0.24% | 0.71% | -2.8% | 8.8% | · | 1.4% | 5.6% | |
| Pretax Margin | 14.6% | 1.8% | 7.5% | 0.46% | -1.4% | -6.8% | 9.2% | · | 0.74% | -0.33% | |
| EBITDA Margin | 14.7% | 2.8% | 9.5% | 3.6% | 1.2% | -4.7% | 10.2% | · | 1.5% | 0.36% | |
| ROA | 10.6% | 0.91% | 6.2% | -0.15% | 0.49% | -2.1% | 7.9% | · | 1.2% | 4.8% | |
| ROE | 13.1% | 1.2% | 8.0% | -0.20% | 0.64% | -2.8% | 10.7% | · | 1.4% | 5.6% | |
| ROIC | 11.5% | 0.54% | 7.1% | -0.31% | 0.20% | -3.1% | 9.2% | · | 0.72% | 8.6% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | 6.0 | 6.1 | 5.2 | 5.5 | 5.8 | 5.1 | · | 7.4 | 7.4 | |
| Quick Ratio | 2.1 | 3.1 | 2.4 | 1.9 | 1.6 | 3.6 | 3.2 | · | 5.3 | 4.8 | |
| Interest Coverage | · | · | 42.3 | · | · | · | · | · | · | · |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.8 | 0.7 | 0.6 | 0.7 | 0.8 | 0.9 | · | 0.9 | 0.9 | |
| Inventory Turnover | 1.1 | 1.1 | 1.0 | 1.0 | 1.1 | 1.2 | 1.3 | · | 1.4 | 1.4 | |
| Receivables Turnover | 7.8 | 6.5 | 5.2 | 5.0 | 5.5 | 5.1 | 5.8 | · | 6.6 | 7.2 |
Stopy Wzrostu 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 17.5% | 12.9% | 24.9% | 13.3% | 33.4% | · | · | · | · | · | |
| Revenue CAGR 3Y | 18.3% | 16.9% | 23.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 20.2% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 1155.6% | -84.5% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 37.0% | · | · | · | · | · | · | · | · | |
| Net Income YoY | 1168.1% | -84.6% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 38.4% | · | · | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.40B | $1.19B | $1.06B | $847M | $748M | $560M | $547M | · | $334M | $263M | |
| Net Income TTM | $178M | $14M | $91M | $-2M | $5M | $-16M | $48M | · | $5M | $15M | |
| Market Cap | $12.20B | $9.14B | $9.73B | $8.48B | $10.80B | $6.37B | $5.75B | · | $3.17B | $1.98B | |
| P/E | 68.8 | 659.7 | 108.4 | -4449.2 | 2052.3 | -397.7 | 122.6 | · | 723.8 | 145.0 | |
| P/S | 8.7 | 7.7 | 9.2 | 10.0 | 14.4 | 11.4 | 10.5 | · | 9.5 | 7.5 | |
| P/B | 8.5 | 7.9 | 8.3 | 8.5 | 11.3 | 9.9 | 11.8 | · | 7.9 | 7.4 | |
| P / Tangible Book | 9.7 | 9.3 | 10.3 | 11.3 | 15.5 | 10.3 | · | · | · | · | |
| P / Cash Flow | 51.1 | 54.3 | 100.0 | -152.3 | 1136.3 | -191.7 | 215.7 | · | 249.8 | -155.0 | |
| P / FCF | 69.7 | 62.1 | 118.5 | -113.1 | -924.6 | -109.9 | 1265.6 | · | 19935.7 | -75.1 | |
| Earnings Yield | 1.5% | 0.15% | 0.92% | -0.02% | 0.05% | -0.25% | 0.82% | · | 0.14% | 0.69% |
Rachunek zysków i strat 18
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $390M | $375M | $385M | $355M | $339M | $324M | $316M | $301M | $299M | $279M | $285M | $271M | $261M | $241M | $221M | $214M | |
| Cost of Revenue | $125M | $121M | $123M | $114M | $115M | $108M | $105M | $101M | $137M | $98M | $98M | $93M | $95M | $90M | $83M | $78M | |
| Gross Profit | $265M | $253M | $262M | $240M | $224M | $216M | $211M | $200M | $163M | $181M | $187M | $178M | $167M | $151M | $138M | $135M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | · | $22M | $20M | · | $21M | |
| SG&A Expense | $199M | $193M | $181M | $169M | $160M | $153M | $148M | $140M | $142M | $144M | $130M | $126M | $127M | $123M | $116M | $109M | |
| Operating Expenses | $224M | $215M | $203M | $192M | $183M | $176M | $168M | $165M | $244M | $169M | $152M | $165M | $149M | $143M | $134M | $130M | |
| Operating Income | $41M | $38M | $59M | $49M | $41M | $40M | $43M | $35M | $-81M | $12M | $35M | $13M | $18M | $8M | $5M | $5M | |
| Interest Expense | · | · | · | · | · | · | · | · | $344.0K | $402.0K | · | · | $444.0K | $416.0K | · | · | |
| Interest Income | $6M | $5M | $5M | $4M | $4M | $3M | $3M | $3M | $4M | $3M | $3M | $2M | $1M | $970.0K | · | · | |
| Other Non-op | $-456.0K | $-1M | $171.0K | $-535.0K | $812.0K | $445.0K | $-1M | $1M | $-226.0K | $-366.0K | $559.0K | $-444.0K | $808.0K | $90.0K | $2M | $-2M | |
| Pretax Income | $46M | $42M | $64M | $52M | $45M | $44M | $44M | $40M | $-78M | $15M | $38M | $13M | $20M | $9M | $7M | $3M | |
| Income Tax | $11M | $9M | $16M | $6M | $0 | $5M | $11M | $10M | $-18M | $4M | $-16M | $4M | $576.0K | $90.0K | $3M | $5M | |
| Net Income | $35M | $33M | $47M | $46M | $45M | $39M | $34M | $30M | $-60M | $11M | $54M | $9M | $19M | $9M | $4M | $-2M | |
| EPS (Basic) | $0.88 | $0.83 | $1.21 | $1.17 | $1.17 | $1.02 | $0.87 | $0.76 | $-1.55 | $0.28 | $1.42 | $0.24 | $0.49 | $0.22 | $0.11 | $-0.06 | |
| EPS (Diluted) | $0.88 | $0.82 | $1.20 | $1.17 | $1.15 | $1.00 | $0.88 | $0.75 | $-1.55 | $0.28 | $1.39 | $0.23 | $0.48 | $0.22 | $0.11 | $-0.06 | |
| Shares (Basic) | 39,353,965 | 39,275,424 | -77,556,993 | 39,078,378 | 38,834,917 | 38,562,191 | -77,487,736 | 38,610,805 | 38,793,341 | 38,717,334 | -76,568,633 | 38,462,463 | 38,320,999 | 38,186,342 | -75,490,219 | 37,918,452 | |
| Shares (Diluted) | 39,572,059 | 39,543,780 | -78,419,792 | 39,302,239 | 39,245,953 | 39,163,428 | -78,090,890 | 39,178,227 | 38,793,341 | 39,387,359 | -78,279,945 | 39,219,966 | 39,201,155 | 39,075,388 | -76,552,754 | 37,918,452 | |
| EBITDA | $41M | $43M | · | $49M | $41M | $45M | · | $35M | $-81M | $20M | · | $13M | $18M | $15M | · | $5M |
Bilans 25
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $241M | $187M | $321M | $422M | $376M | $324M | $280M | $288M | $223M | · | $101M | $114M | $95M | · | $55M | |
| Receivables | $190M | $183M | $190M | $183M | $176M | $168M | $168M | $176M | $201M | $192M | · | $207M | $209M | $207M | · | $189M | |
| Inventory | $443M | $439M | $432M | $432M | $428M | $416M | $407M | $393M | $374M | $398M | · | $374M | $359M | $344M | · | $320M | |
| Prepaid Expense | $52M | $38M | $50M | $55M | $38M | $37M | $37M | $31M | $29M | $31M | · | $39M | $39M | $36M | · | $30M | |
| Current Assets | $1.34B | $1.28B | $1.22B | $1.14B | $1.07B | $1000M | $951M | $892M | $944M | $935M | · | $868M | $828M | $786M | · | $724M | |
| PP&E (Net) | $147M | $134M | $117M | $98M | $85M | $72M | $63M | $60M | $58M | $76M | · | $66M | $66M | $65M | · | $64M | |
| PP&E (Gross) | · | · | $194M | · | · | · | $137M | $132M | $143M | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $77M | · | · | · | $74M | $72M | $85M | · | · | · | · | · | · | · | |
| Goodwill | $167M | $167M | $167M | $167M | $167M | $166M | $166M | $166M | $166M | $166M | · | $166M | $166M | $166M | · | $165M | |
| Intangibles | $6M | $6M | $6M | $6M | $7M | $6M | $7M | $7M | $7M | $68M | · | $73M | $76M | $79M | · | $83M | |
| Other Non-current Assets | $41M | $41M | $41M | $40M | $40M | $44M | $41M | $39M | $39M | $34M | · | $15M | $10M | $11M | · | $13M | |
| Total Assets | $1.97B | $1.90B | $1.83B | $1.74B | $1.67B | $1.59B | $1.53B | $1.48B | $1.53B | $1.58B | · | $1.47B | $1.43B | $1.40B | · | $1.32B | |
| Accounts Payable | $45M | $44M | $35M | $30M | $28M | $31M | $31M | $33M | $33M | $32M | · | $28M | $26M | $28M | · | $25M | |
| Accrued Liabilities | $172M | $152M | $132M | $124M | $114M | $113M | $112M | $106M | $104M | $107M | · | $104M | $106M | $106M | · | $102M | |
| Current Liabilities | $234M | $212M | $183M | $170M | $158M | $159M | $158M | $153M | $151M | $153M | · | $145M | $144M | $146M | · | $138M | |
| Capital Leases | $176M | $179M | $183M | $180M | $183M | $185M | $187M | $190M | $192M | $195M | · | $192M | $195M | $197M | · | $181M | |
| Other Non-current Liabilities | $14M | $13M | $12M | $15M | $18M | $16M | $15M | $9M | $8M | $6M | · | $3M | $3M | $3M | · | $3M | |
| Total Liabilities | $444M | $425M | $399M | $386M | $381M | $380M | $382M | $375M | $373M | $376M | · | $364M | $366M | $371M | · | $348M | |
| Common Stock | $39.0K | $39.0K | $39.0K | $39.0K | $39.0K | $39.0K | $38.0K | $38.0K | $39.0K | $39.0K | · | $38.0K | $38.0K | $38.0K | · | $38.0K | |
| Paid-in Capital | $1.22B | $1.20B | $1.19B | $1.17B | $1.15B | $1.12B | $1.10B | $1.08B | $1.08B | $1.06B | · | $1.03B | $1.00B | $979M | · | $947M | |
| Retained Earnings | $305M | $270M | $238M | $190M | $144M | $99M | $60M | $26M | $86M | $146M | · | $81M | $71M | $52M | · | $40M | |
| AOCI | $1M | $2M | $4M | $3M | $3M | $-3M | $-6M | $-963.0K | $-5M | $-5M | · | $-7M | $-6M | $-7M | · | $-13M | |
| Stockholders' Equity | $1.53B | $1.47B | $1.43B | $1.36B | $1.29B | $1.21B | $1.15B | $1.10B | $1.16B | $1.20B | $1.18B | $1.10B | $1.07B | $1.02B | $999M | $974M | |
| Liabilities + Equity | $1.97B | $1.90B | $1.83B | $1.74B | $1.67B | $1.59B | $1.53B | $1.48B | $1.53B | $1.58B | · | $1.47B | $1.43B | $1.40B | · | $1.32B | |
| Shares Outstanding | · | · | 39,229,670 | · | · | · | 38,490,836 | · | · | · | · | · | · | · | · | · |
Przepływy pieniężne 13
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $5M | $4M | $2M | $6M | $5M | $4M | $4M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | |
| Stock-based Comp | $14M | $15M | $15M | $16M | $14M | $14M | $12M | $11M | $10M | $14M | $11M | $14M | $13M | $13M | $10M | $10M | |
| Amort. of Intangibles | $181.0K | $182.0K | $182.0K | $182.0K | $178.0K | $170.0K | $170.0K | $176.0K | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Restructuring | · | · | · | · | · | · | · | $5M | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $35M | · | · | · | $-9M | · | · | · | $6M | · | · | · | $-15M | · | · | |
| Operating Cash Flow | $46M | $87M | $86M | $58M | $45M | $49M | $51M | $56M | $23M | $38M | $36M | $31M | $17M | $13M | $1M | $-13M | |
| CapEx | $14M | $14M | $18M | $16M | $16M | $13M | $5M | $5M | $5M | $6M | $4M | $3M | $4M | $4M | $4M | $6M | |
| Investing Cash Flow | $-91M | $-31M | $-226M | $-163M | $-16M | $-502.0K | $-11M | $36M | $34M | $18M | $24M | $-44M | $-7M | $11M | $9M | $10M | |
| Stock Repurchased | · | · | $0 | · | · | · | $-1.0K | · | · | · | $0 | · | · | · | · | · | |
| Financing Cash Flow | $9M | $-2M | $5M | $4M | $15M | $3M | $6M | $-101M | $8M | $-794.0K | $6M | $212.0K | $9M | $1M | $6M | $-603.0K | |
| Net Change in Cash | $-36M | $54M | $-134M | $-101M | $46M | $52M | $44M | $-8M | $65M | $56M | $67M | $-13M | $19M | $25M | $15M | $-3M | |
| Free Cash Flow | · | $73M | · | · | · | $36M | · | · | · | $32M | · | · | · | $9M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $32M | · | · | · | · | · | · |
Rentowność 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.9% | 67.6% | · | 67.8% | 66.0% | 66.6% | · | 66.5% | 54.4% | 65.0% | · | 65.6% | 63.8% | 62.6% | · | 63.3% | |
| Operating Margin | 10.5% | 10.2% | · | 13.8% | 12.0% | 12.4% | · | 11.8% | -27.0% | 4.3% | · | 4.7% | 6.8% | 3.3% | · | 2.5% | |
| Net Margin | 8.9% | 8.7% | · | 12.9% | 13.3% | 12.1% | · | 9.8% | -20.1% | 4.0% | · | 3.4% | 7.2% | 3.5% | · | -1.1% | |
| Pretax Margin | 11.8% | 11.1% | · | 14.8% | 13.4% | 13.5% | · | 13.2% | -26.0% | 5.2% | · | 4.9% | 7.5% | 3.6% | · | 1.4% | |
| EBITDA Margin | 10.5% | 11.4% | · | 13.8% | 12.0% | 14.0% | · | 11.8% | -27.0% | 7.0% | · | 4.7% | 6.8% | 6.0% | · | 2.5% | |
| ROA | 1.9% | 1.9% | · | 2.8% | 2.8% | 2.5% | · | 2.0% | -4.1% | 0.74% | · | 0.66% | 1.4% | 0.63% | · | -0.20% | |
| ROE | 2.5% | 2.4% | · | 3.7% | 3.7% | 3.2% | · | 2.7% | -5.4% | 0.99% | · | 0.89% | 1.9% | 0.86% | · | -0.27% | |
| ROIC | 2.0% | 2.0% | · | 3.1% | 3.2% | 3.0% | · | 2.4% | -5.4% | 0.76% | · | 0.79% | 1.6% | 0.77% | · | -0.42% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 6.0 | · | 6.7 | 6.8 | 6.3 | · | 5.8 | 6.3 | 6.1 | · | 6.0 | 5.7 | 5.4 | · | 5.2 | |
| Quick Ratio | 1.7 | 2.0 | · | 3.0 | 3.8 | 3.4 | · | 3.0 | 3.2 | 2.7 | · | 2.1 | 2.2 | 2.1 | · | 1.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -235.4 | 30.1 | · | · | · | · | · | · |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 2.1 | 2.1 | · | 2.0 | 1.8 | 1.8 | · | 1.6 | 1.5 | 1.4 | · | 1.4 | 1.3 | 1.4 | · | 1.4 |
Wycena (TTM) 4
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.46B | $1.39B | · | $1.32B | $1.26B | $1.20B | · | $1.16B | $1.13B | $1.10B | · | $995M | $938M | $885M | · | $830M | |
| Net Income TTM | $159M | $163M | · | $160M | $54M | $20M | · | $35M | $14M | $93M | · | $41M | $29M | $6M | · | $-31M | |
| P/E | 78.5 | 79.3 | · | 62.2 | 190.1 | 557.1 | · | 225.9 | 529.3 | 94.2 | · | 234.9 | 464.9 | 1741.8 | · | -231.2 | |
| Earnings Yield | 1.3% | 1.3% | · | 1.6% | 0.53% | 0.18% | · | 0.44% | 0.19% | 1.1% | · | 0.43% | 0.22% | 0.06% | · | -0.43% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $1.40B | $1.19B | $1.06B | $847M | $748M |
| Marża Brutto % | 67.1% | 63.2% | 64.5% | 63.2% | 63.6% |
| Marża Operacyjna % | 13.5% | 0.78% | 7.0% | 0.72% | -1.0% |
| Zysk netto | $178M | $14M | $91M | $-2M | $5M |
| Rozwodniony EPS | $4.52 | $0.36 | $2.32 | $-0.05 | $0.14 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 6.6 | 6.0 | 6.1 | 5.2 | 5.5 |
| Wskaźnik Szybkości | 2.1 | 3.1 | 2.4 | 1.9 | 1.6 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $175M | $147M | $82M | $-75M | $-12M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 495 emitentów · $9.1B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 53 (-81 vs poprzedni kw.) | 66 (-9 vs poprzedni kw.) | 143 (-2 vs poprzedni kw.) | 173 (+36 vs poprzedni kw.) | +5.0M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1 079 172 030 | 3 471 011 | 11,84% | Akcje |
| HBK INVESTMENTS L P | $580 508 901 | 1 838 508 | 6,37% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $539 893 663 | 1 709 877 | 5,92% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $526 442 397 | 1 667 276 | 5,78% | Akcje |
| STATE STREET CORP | $392 556 505 | 1 243 258 | 4,31% | Akcje |
| ExodusPoint Capital Management, LP | $344 303 272 | 1 090 430 | 3,78% | Akcje |
| Balyasny Asset Management L.P. | $344 218 967 | 1 090 163 | 3,78% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $263 620 622 | 834 903 | 2,89% | Akcje |
| NORGES BANK | $237 520 412 | 752 242 | 2,61% | Akcje |
| GOLDMAN SACHS GROUP INC | $224 295 223 | 710 357 | 2,46% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $221 217 923 | 700 611 | 2,43% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $204 339 887 | 646 966 | 2,24% | Akcje |
| AQR Arbitrage LLC | $178 042 900 | 563 873 | 1,95% | Akcje |
| WHITEBOX ADVISORS LLC | $160 047 676 | 506 881 | 1,76% | Akcje |
| Capital World Investors | $151 465 591 | 479 701 | 1,66% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $138 473 110 | 438 553 | 1,52% | Akcje |
| CITADEL ADVISORS LLC | $137 163 063 | 434 404 | 1,50% | Akcje |
| CITIGROUP INC | $136 606 712 | 432 642 | 1,50% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $135 181 416 | 428 128 | 1,48% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $126 504 922 | 400 649 | 1,39% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $99 031 466 | 301 585 | 1,09% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $91 636 018 | 290 217 | 1,01% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $79 488 800 | 251 746 | 0,87% | Akcje |
| Champlain Investment Partners, LLC | $69 159 354 | 219 032 | 0,76% | Akcje |
| TIG Advisors, LLC | $67 912 141 | 215 082 | 0,74% | Akcje |
| BANK OF AMERICA CORP /DE/ | $65 549 700 | 207 600 | 0,72% | Akcje |
| FMR LLC | $64 584 768 | 204 544 | 0,71% | Akcje |
| Hudson Bay Capital Management LP | $64 140 823 | 203 138 | 0,70% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $63 150 000 | 200 000 | 0,69% | Opcja sprzedaży |
| D. E. Shaw & Co., Inc. | $59 920 825 | 189 773 | 0,66% | Akcje |
| ALPINE ASSOCIATES MANAGEMENT INC. | $59 672 330 | 188 986 | 0,65% | Akcje |
| Melqart Asset Management (UK) Ltd | $58 645 511 | 185 734 | 0,64% | Akcje |
| CAXTON ASSOCIATES LLP | $56 640 498 | 179 384 | 0,62% | Akcje |
| Magnetar Financial LLC | $56 303 909 | 178 318 | 0,62% | Akcje |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $55 799 340 | 176 720 | 0,61% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $55 540 425 | 175 900 | 0,61% | Opcja sprzedaży |
| JANUS HENDERSON GROUP PLC | $48 872 949 | 148 835 | 0,54% | Akcje |
| WATER ISLAND CAPITAL LLC | $47 506 483 | 150 456 | 0,52% | Akcje |
| Woodline Partners LP | $46 050 243 | 145 844 | 0,51% | Akcje |
| Verition Fund Management LLC | $44 934 067 | 142 309 | 0,49% | Akcje |
| Decagon Asset Management LLP | $44 836 816 | 142 001 | 0,49% | Akcje |
| Westchester Capital Management, LLC | $44 445 917 | 140 763 | 0,49% | Akcje |
| Squarepoint Ops LLC | $43 703 905 | 138 413 | 0,48% | Akcje |
| Slotnik Capital, LLC | $41 994 750 | 133 000 | 0,46% | Akcje |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $41 487 656 | 131 394 | 0,46% | Akcje |
| Holocene Advisors, LP | $40 419 789 | 128 012 | 0,44% | Akcje |
| NATIXIS | $39 297 614 | 124 458 | 0,43% | Akcje |
| Rock Springs Capital Management LP | $36 548 063 | 115 750 | 0,40% | Akcje |
| RHUMBLINE ADVISERS | $34 473 523 | 109 180 | 0,38% | Akcje |
| Kryger Capital LLC | $33 850 610 | 107 207 | 0,37% | Akcje |
| Birnam Oak Advisors, LP | $33 539 597 | 106 222 | 0,37% | Akcje |
| Calamos Advisors LLC | $29 005 742 | 91 863 | 0,32% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $28 061 650 | 88 873 | 0,31% | Akcje |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $27 258 698 | 86 330 | 0,30% | Akcje |
| Empyrean Capital Partners, LP | $26 838 750 | 85 000 | 0,29% | Akcje |
| Capula Management Ltd | $26 207 250 | 83 000 | 0,29% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $26 202 514 | 82 985 | 0,29% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $25 102 125 | 79 500 | 0,28% | Akcje |
| PICTON MAHONEY ASSET MANAGEMENT | $23 744 407 | 75 200 | 0,26% | Akcje |
| Swiss National Bank | $23 674 935 | 74 980 | 0,26% | Akcje |
| CARRET ASSET MANAGEMENT, LLC | $22 734 000 | 72 000 | 0,25% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $21 137 884 | 66 945 | 0,23% | Akcje |
| Quarry LP | $20 595 426 | 65 227 | 0,23% | Akcje |
| California Public Employees Retirement System | $20 311 250 | 64 327 | 0,22% | Akcje |
| Man Group plc | $19 430 939 | 61 539 | 0,21% | Akcje |
| PFM Health Sciences, LP | $19 014 781 | 60 221 | 0,21% | Akcje |
| BlackRock, Inc. | $19 005 940 | 60 193 | 0,21% | Akcje |
| HARVEST MANAGEMENT LLC | $18 151 520 | 57 487 | 0,20% | Akcje |
| Sculptor Capital LP | $17 997 750 | 57 000 | 0,20% | Akcje |
| GABELLI & Co INVESTMENT ADVISERS, INC. | $16 826 949 | 53 292 | 0,18% | Akcje |
| GABELLI FUNDS LLC | $16 552 562 | 52 423 | 0,18% | Akcje |
| Congress Wealth Management LLC / DE / | $16 513 112 | 64 346 | 0,18% | Akcje |
| CREDIT INDUSTRIEL ET COMMERCIAL | $16 443 629 | 52 078 | 0,18% | Akcje |
| FIRST TRUST ADVISORS LP | $15 529 450 | 49 183 | 0,17% | Akcje |
| MARSHALL WACE, LLP | $15 420 914 | 48 839 | 0,17% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $14 840 250 | 47 000 | 0,16% | Opcja kupna |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $14 115 641 | 42 987 | 0,15% | Akcje |
| Retirement Systems of Alabama | $12 844 710 | 40 680 | 0,14% | Akcje |
| Walleye Trading LLC | $12 251 100 | 38 800 | 0,13% | Opcja sprzedaży |
| CSS LLC/IL | $12 232 155 | 38 740 | 0,13% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $11 976 713 | 37 931 | 0,13% | Akcje |
| CITADEL ADVISORS LLC | $11 872 200 | 37 600 | 0,13% | Opcja sprzedaży |
| Walleye Trading LLC | $11 619 600 | 36 800 | 0,13% | Opcja kupna |
| PRELUDE CAPITAL MANAGEMENT, LLC | $11 487 301 | 36 381 | 0,13% | Akcje |
| Yakira Capital Management, Inc. | $11 430 150 | 36 200 | 0,13% | Opcja sprzedaży |
| CSS LLC/IL | $11 398 575 | 36 100 | 0,13% | Opcja sprzedaży |
| VANGUARD ASSET MANAGEMENT, Ltd | $11 382 472 | 36 049 | 0,12% | Akcje |
| AMERIPRISE FINANCIAL INC | $10 798 651 | 34 200 | 0,12% | Akcje |
| Alberta Investment Management Corp | $10 457 640 | 33 120 | 0,11% | Akcje |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $10 430 170 | 33 033 | 0,11% | Akcje |
| CIBRA Capital Ltd | $10 376 492 | 31 600 | 0,11% | Akcje |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $10 238 194 | 32 425 | 0,11% | Akcje |
| Gotham Asset Management, LLC | $10 139 048 | 32 111 | 0,11% | Akcje |
| LMR Partners LLP | $10 014 643 | 31 717 | 0,11% | Akcje |
| CITIZENS FINANCIAL GROUP INC/RI | $9 878 555 | 31 286 | 0,11% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $9 872 171 | 31 266 | 0,11% | Akcje |
| Hudson Bay Capital Management LP | $9 567 225 | 30 300 | 0,10% | Opcja sprzedaży |
| ING GROEP NV | $9 472 500 | 30 000 | 0,10% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9 203 797 | 29 149 | 0,10% | Akcje |
| JANE STREET GROUP, LLC | $8 904 150 | 28 200 | 0,10% | Opcja sprzedaży |
Insiderzy spółki 18 insiderów · 0 dyrektorzy generalni · 1 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Walter Charles Wang | Dyrektor | 4 marca 2016 A | 521 071 | 0 | 0 | $0 |
| Harpreet Grewal | — | 2 kwietnia 2026 S | 8 719 | 0 | 6 | $-259 469 |
| Arani Bose | — | 25 kwietnia 2025 S | 302 819 | 0 | 0 | $0 |
| Adam Elsesser | — | 16 kwietnia 2025 M | 63 911 | 0 | 0 | $0 |
| Bridget O'Rourke | — | 15 kwietnia 2025 S | 5 523 | 0 | 0 | $0 |
| Thomas Wilder | — | 2 kwietnia 2025 S | 4 692 | 0 | 0 | $0 |
| Johanna Roberts | — | 1 kwietnia 2025 M | 66 353 | 0 | 0 | $0 |
| Lambert Shiu | — | 15 marca 2025 F | 32 756 | 0 | 0 | $0 |
| Maggie Yuen | — | 15 marca 2025 F | 15 957 | 0 | 0 | $0 |
| Surbhi Sarna | — | 14 lutego 2025 A | 3 704 | 0 | 0 | $0 |
| Janet Leeds | — | 14 lutego 2025 A | 6 050 | 0 | 0 | $0 |
| Don W. Kassing | — | 14 lutego 2025 A | 1 409 | 0 | 0 | $0 |
| James Robert Pray | — | 1 października 2021 S | 408 431 | 0 | 0 | $0 |
| Lynn Rothman | — | 1 października 2021 M | 32 637 | 0 | 0 | $0 |
| Sridhar Kosaraju | — | 15 kwietnia 2020 S | 155 351 | 0 | 0 | $0 |
| Daniel Donen Davis | — | 27 grudnia 2018 M | 64 277 | 0 | 0 | $0 |
| Robert D. Evans | — | 30 sierpnia 2018 M | 15 667 | 0 | 0 | $0 |
| Kevin James Sullivan | — | 31 sierpnia 2016 S | 29 449 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 94 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| RSBA · Tidal Trust II | 12,36% | 19 894 NS | 30 kwietnia 2026 | N-PORT |
| TMFS · RBB Fund, Inc. | 3,49% | 6 500 NS | 31 maja 2026 | N-PORT |
| CSMD · Professionally Managed Portfolios | 2,79% | 36 963 NS | 30 kwietnia 2026 | N-PORT |
| ARB · AltShares Trust | 2,71% | 8 763 NS | 31 maja 2026 | N-PORT |
| EVNT · AltShares Trust | 2,57% | 988 NS | 31 maja 2026 | N-PORT |
| TMFM · RBB Fund, Inc. | 2,47% | 9 045 NS | 31 maja 2026 | N-PORT |
| MNA · New York Life Investments ETF Trust | 2,08% | 15 907 NS | 30 kwietnia 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,85% | 3 021 NS | 30 kwietnia 2026 | N-PORT |
| IHI · iShares Trust | 1,81% | 186 372 SH | 8 sierpnia 2026 | Dziennie |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,72% | 46 100 NS | 30 kwietnia 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 1,61% | 1 015 NS | 31 maja 2026 | N-PORT |
| QGRO · AMERICAN CENTURY ETF TRUST | 0,94% | 64 901 NS | 31 maja 2026 | N-PORT |
| RFG · Invesco Exchange-Traded Fund Trust | 0,93% | 10 222 SH | 8 sierpnia 2026 | Dziennie |
| XMMO · Invesco Exchange-Traded Fund Trust | 0,82% | 190 613 SH | 8 sierpnia 2026 | Dziennie |
| IJK · iShares Trust | 0,68% | 230 205 SH | 8 sierpnia 2026 | Dziennie |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,65% | 38 809 SH | 8 sierpnia 2026 | Dziennie |
| IQSM · New York Life Investments ETF Trust | 0,50% | 4 861 NS | 30 kwietnia 2026 | N-PORT |
| MIDE · DBX ETF Trust | 0,50% | 53 NS | 29 maja 2026 | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 0,50% | 43 850 NS | 31 maja 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,43% | 16 945 NS | 30 kwietnia 2026 | N-PORT |
| PAMC · Pacer Funds Trust | 0,43% | 825 NS | 30 kwietnia 2026 | N-PORT |
| SMMV · iShares Trust | 0,41% | 3 623 SH | 8 sierpnia 2026 | Dziennie |
| XJH · iShares Trust | 0,40% | 5 322 SH | 8 sierpnia 2026 | Dziennie |
| ISCG · iShares Trust | 0,39% | 11 923 SH | 8 sierpnia 2026 | Dziennie |
| PTMC · Pacer Funds Trust | 0,37% | 4 504 NS | 30 kwietnia 2026 | N-PORT |
| IWP · iShares Trust | 0,35% | 220 066 SH | 8 sierpnia 2026 | Dziennie |
| IJH · iShares Trust | 0,35% | 1 357 187 SH | 8 sierpnia 2026 | Dziennie |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,34% | 63 544 SH | 8 sierpnia 2026 | Dziennie |
| VBK · VANGUARD INDEX FUNDS | 0,32% | 495 123 SH | 8 sierpnia 2026 | Dziennie |
| BKMC · BNY Mellon ETF Trust | 0,32% | 6 084 NS | 30 kwietnia 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,31% | 4 084 NS | 30 kwietnia 2026 | N-PORT |
| MVV · ProShares Trust | 0,27% | 1 355 NS | 31 maja 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,25% | 650 NS | 30 kwietnia 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,25% | 960 NS | 30 kwietnia 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,24% | 17 656 NS | 30 kwietnia 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,24% | 15 077 NS | 30 kwietnia 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0,23% | 106 066 NS | 31 maja 2026 | N-PORT |
| BFOR · ALPS ETF Trust | 0,22% | 1 474 NS | 31 maja 2026 | N-PORT |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 49 882 NS | 30 kwietnia 2026 | N-PORT |
| IYH · iShares Trust | 0,20% | 22 788 SH | 8 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,20% | 17 152 NS | 30 kwietnia 2026 | N-PORT |
| ISCB · iShares Trust | 0,19% | 1 690 SH | 8 sierpnia 2026 | Dziennie |
| UMDD · ProShares Trust | 0,19% | 189 NS | 31 maja 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 12 265 NS | 30 kwietnia 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,17% | 112 334 SH | 8 sierpnia 2026 | Dziennie |
| ESML · iShares Trust | 0,17% | 15 104 SH | 8 sierpnia 2026 | Dziennie |
| SMMD · iShares Trust | 0,16% | 18 985 SH | 8 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,14% | 12 861 SH | 8 sierpnia 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,14% | 451 358 SH | 8 sierpnia 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,14% | 856 800 SH | 8 sierpnia 2026 | Dziennie |